NI
AZN icon

Natural Investments’s AstraZeneca AZN Stock Holding History

Natural Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Buy
+13,360
New +$2.51M 0.56% 35
2026
Q1 		– Sell
-20,840
Closed -$3.83M – 290
2025
Q4 		$3.83M Sell
20,840
-1,396
-6% -$245K 0.95% 20
2025
Q3 		$3.41M Buy
22,236
+101
+0.5% +$15.3K 0.85% 25
2025
Q2 		$3.09M Sell
22,135
-696
-3% -$97.5K 0.8% 27
2025
Q1 		$3.36M Sell
22,831
-246
-1% -$35.6K 0.95% 20
2024
Q4 		$3.02M Buy
+23,077
New +$3.23M 0.84% 25

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Natural Investments's AZN Position: Q2 2026 in Review

Natural Investments opened a new position in AstraZeneca (AZN) in Q2 2026: 13,360 shares worth $2.53M. The stake represents 0.56% of the portfolio and ranks #35 among its holdings. This is a return to the name: Natural Investments previously reported a position in AZN as recently as Q4 2025.

Natural Investments first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.83M in Q4 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Natural Investments held 13,360 shares of AstraZeneca worth $2.53M as of Q2 2026.
  • AstraZeneca was a new Natural Investments position in Q2 2026.
  • AstraZeneca made up 0.56% of Natural Investments's portfolio in Q2 2026, its #35 holding.
  • Natural Investments first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
  • Natural Investments's AstraZeneca position peaked at $3.83M in Q4 2025.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.